Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 298,139 | 514,542 | 575,140 | 697,526 | 790,675 |
| Marketable Securities | 978,473 | 1,176,115 | 944,381 | 629,218 | 437,870 |
| Receivables | 684,242 | 584,603 | 581,052 | 666,960 | 687,609 |
| Inventories | 337,619 | 326,843 | 310,934 | 308,254 | 295,260 |
| Other current assets | 379,477 | 373,324 | 425,781 | 386,665 | 416,901 |
| TOTAL | $2,677,950 | $2,975,427 | $2,837,288 | $2,688,623 | $2,628,315 |
| Non-Current Assets | |||||
| PPE Net | 1,617,459 | 1,571,387 | 1,572,259 | 1,712,869 | 1,673,502 |
| Investments And Advances | 1,840,880 | 1,748,285 | 1,587,229 | 1,395,306 | 1,113,549 |
| Intangibles | 2,977,260 | 2,754,505 | 2,805,428 | 2,825,181 | 2,878,158 |
| Other Non-Current Assets | 0 | 0 | 0 | -1 | 0 |
| TOTAL | $6,435,599 | $6,074,177 | $5,964,916 | $5,933,355 | $5,665,209 |
| Total Assets | $9,113,549 | $9,049,604 | $8,802,204 | $8,621,979 | $8,293,524 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 173,330 | 186,448 | 159,197 | 170,746 | 159,136 |
| Accrued Expenses | 660,562 | 677,210 | 674,743 | 641,273 | 591,448 |
| TOTAL | $1,337,319 | $912,889 | $885,346 | $954,330 | $978,846 |
| Non-Current Liabilities | |||||
| Long Term Debt | 626,012 | 1,060,808 | 1,060,639 | 1,062,986 | 1,065,613 |
| aiOther Non-Current Liabilities | 517,701 | 400,304 | 382,614 | 335,670 | 341,826 |
| TOTAL | $1,467,682 | $1,709,728 | $1,683,264 | $1,611,455 | $1,640,378 |
| Total Liabilities | $2,805,001 | $2,622,617 | $2,568,610 | $2,565,785 | $2,619,224 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 239,563 | 238,725 | 242,917 | 242,546 | 241,632 |
| Common Shares | 129 | 128 | 128 | 127 | 125 |
| Retained earnings | 3,409,308 | 3,106,761 | 2,806,523 | 2,454,848 | 2,166,813 |
| Other shareholders' equity | -15,137 | -24,950 | 12,514 | 105,354 | 68,934 |
| TOTAL | $6,308,548 | $6,426,987 | $6,233,594 | $6,056,194 | $5,674,300 |
| Total Liabilities And Equity | $9,113,549 | $9,049,604 | $8,802,204 | $8,621,979 | $8,293,524 |